Table 4.
Logistic regression analyses for elevated CIMT in diabetic and non-diabetic subjects.
| non-DM | DM | |||
|---|---|---|---|---|
| Model | OR (95% CI) | P-value | OR (95% CI) | P-value |
| LOG MHR | ||||
| Model 1 | 1.133 (0.878–1.463) | 0.337 | 1.886 (1.144–3.107) | 0.013 |
| Model 2 | 1.070 (0.799–1.431) | 0.651 | 1.756 (1.030–2.993) | 0.038 |
| Model 3 | 0.876 (0.619–1.238) | 0.453 | 2.237 (1.172–4.270) | 0.015 |
| HDL CHOLESTEROL | ||||
| Model 1 | 0.964 (0.670–1.388) | 0.845 | 0.522 (0.262–1.039) | 0.064 |
| Model 2 | 0.951 (0.636–1.421) | 0.805 | 0.541 (0.249–1.060) | 0.071 |
| Model 3 | 1.351 (0.832–2.193) | 0.224 | 0.454 (0.182–1.133) | 0.091 |
| LDL CHOLESTEROL | ||||
| Model 1 | 1.211 (1.064–1.379) | 0.004 | 1.093 (0.883–1.352) | 0.416 |
| Model 2 | 1.335 (1.165–1.531) | <0.001 | 1.193 (0.955–1.489) | 0.120 |
| Model 3 | 1.325 (1.140–1.539) | <0.001 | 1.166 (0.897–1.516) | 0.252 |
| non-HDL CHOLESTEROL | ||||
| Model 1 | 1.154 (1.035–1.286) | 0.010 | 1.040 (0.876–1.234) | 0.657 |
| Model 2 | 1.253 (1.117–1.404) | <0.001 | 1.134 (0.948–1.357) | 0.170 |
| Model 3 | 1.252 (1.091–1.435) | 0.001 | 1.034 (0.803–1.332) | 0.795 |
| APOLIPOPROTEIN A-I | ||||
| Model 1 | 1.014 (0.598–1.719) | 0.960 | 0.502 (0.205–1.229) | 0.131 |
| Model 2 | 1.023 (0.569–1.841) | 0.939 | 0.558 (0.217–1.437) | 0.227 |
| Model 3 | 1.322 (0.696–2.511) | 0.394 | 0.326 (0.108–0.977) | 0.045 |
| APOLIPOPROTEIN B | ||||
| Model 1 | 1.821 (1.123–2.953) | 0.015 | 1.192 (0.541–2.625) | 0.662 |
| Model 2 | 2.410 (1.455–3.992) | 0.001 | 1.726 (0.756–3.939) | 0.195 |
| Model 3 | 2.225 (1.233–4.015) | 0.008 | 1.587 (0.555–4.540) | 0.389 |
Model 1 is unadjusted model; Model 2 is adjusted for age, sex, history of hypertension and smoking; Model 3 is adjusted for age, sex, history of hypertension and smoking, eGFR, logarithmically transformed levels of C-reactive protein, HbA1c and triglyceride.